GeoVax Labs, Inc. New (GOVX) is a publicly traded Healthcare sector company. As of October 27, 2026, GOVX trades at $0.20 with a market cap of $1.87M and a P/E ratio of -0.01. GOVX moved +0.00% today. Year to date, GOVX is -96.24%; over the trailing twelve months it is -98.63%. Its 52-week range spans $0.19 to $47.13. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces GOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for GOVX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.20 |
| Market Cap | $1.87M |
| P/E Ratio | -0.01 |
| EPS | $-22.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.13 |
| 52-Week Low | $0.19 |
| Volume | 86.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.49M |
| Net Income | $-21.46M |
| Gross Margin | 0.00% |
1 analysts cover GOVX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.